ATE408032T1 - Esr1 und gebärmutterhalskrebs - Google Patents

Esr1 und gebärmutterhalskrebs

Info

Publication number
ATE408032T1
ATE408032T1 AT05774038T AT05774038T ATE408032T1 AT E408032 T1 ATE408032 T1 AT E408032T1 AT 05774038 T AT05774038 T AT 05774038T AT 05774038 T AT05774038 T AT 05774038T AT E408032 T1 ATE408032 T1 AT E408032T1
Authority
AT
Austria
Prior art keywords
cervical cancer
esr1
kits
genes
incidence
Prior art date
Application number
AT05774038T
Other languages
English (en)
Inventor
Der Zee Ate Van
Bea Wisman
Original Assignee
Oncomethylome Sciences Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0415988A external-priority patent/GB0415988D0/en
Application filed by Oncomethylome Sciences Sa filed Critical Oncomethylome Sciences Sa
Application granted granted Critical
Publication of ATE408032T1 publication Critical patent/ATE408032T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays
AT05774038T 2004-07-16 2005-07-07 Esr1 und gebärmutterhalskrebs ATE408032T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58835004P 2004-07-16 2004-07-16
GB0415988A GB0415988D0 (en) 2004-07-16 2004-07-16 ESR1 and cervical cancer

Publications (1)

Publication Number Publication Date
ATE408032T1 true ATE408032T1 (de) 2008-09-15

Family

ID=35064764

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05774038T ATE408032T1 (de) 2004-07-16 2005-07-07 Esr1 und gebärmutterhalskrebs

Country Status (6)

Country Link
US (1) US20090023137A1 (de)
EP (2) EP1985715A3 (de)
AT (1) ATE408032T1 (de)
CA (1) CA2574165A1 (de)
DE (1) DE602005009702D1 (de)
WO (1) WO2006007980A2 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307403D0 (en) * 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
GB0307428D0 (en) * 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
US20050221339A1 (en) * 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
CA2599055C (en) * 2005-02-14 2016-01-12 The Johns Hopkins University Neoplasia screening compositions and methods of use
US20100137163A1 (en) 2006-01-11 2010-06-03 Link Darren R Microfluidic Devices and Methods of Use in The Formation and Control of Nanoreactors
US7901882B2 (en) 2006-03-31 2011-03-08 Affymetrix, Inc. Analysis of methylation using nucleic acid arrays
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
EP2530168B1 (de) 2006-05-11 2015-09-16 Raindance Technologies, Inc. Mikrofluidische Vorrichtungen
WO2008021123A1 (en) 2006-08-07 2008-02-21 President And Fellows Of Harvard College Fluorocarbon emulsion stabilizing surfactants
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
WO2008130623A1 (en) 2007-04-19 2008-10-30 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
EP2626435B1 (de) 2008-03-21 2016-06-01 MDxHealth S.A. Erkennung und Prognose von Gebärmutterhalskrebs
EP4047367A1 (de) 2008-07-18 2022-08-24 Bio-Rad Laboratories, Inc. Verfahren zum nachweis von zielanalyten unter verwendung von tropfenbibliotheken
EP2411148B1 (de) 2009-03-23 2018-02-21 Raindance Technologies, Inc. Manipulation von mikrofluidiktröpfchen
EP2425015B1 (de) * 2009-04-29 2018-01-10 Ralph Wirtz Verfahren zur beurteilung der prognose und zur vorhersage eines therapieerfolgs bei krebs anhand der bestimmung von hormonrezeptor-expressionsniveaus
EP2486409A1 (de) 2009-10-09 2012-08-15 Universite De Strasbourg Markiertes nanomaterial auf siliziumbasis mit verbesserten eigenschaften und seine verwendung
EP2517025B1 (de) 2009-12-23 2019-11-27 Bio-Rad Laboratories, Inc. Verfahren zur reduzierung des austauschs von molekülen zwischen tröpfchen
EP3392349A1 (de) 2010-02-12 2018-10-24 Raindance Technologies, Inc. Digitale analyse von analyten
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
KR101374822B1 (ko) * 2010-04-23 2014-03-17 (주)지노믹트리 자궁경부암 진단용 메틸화 마커
WO2012045012A2 (en) 2010-09-30 2012-04-05 Raindance Technologies, Inc. Sandwich assays in droplets
EP3412778A1 (de) 2011-02-11 2018-12-12 Raindance Technologies, Inc. Verfahren zur bildung gemischter tröpfchen
EP3736281A1 (de) 2011-02-18 2020-11-11 Bio-Rad Laboratories, Inc. Zusammensetzungen und verfahren für molekulare etikettierung
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
EP2714970B1 (de) 2011-06-02 2017-04-19 Raindance Technologies, Inc. Enzymquantifizierung
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
US20130210659A1 (en) 2012-02-10 2013-08-15 Andrew Watson Molecular diagnostic screening assay
WO2013165748A1 (en) 2012-04-30 2013-11-07 Raindance Technologies, Inc Digital analyte analysis
EP2986762B1 (de) 2013-04-19 2019-11-06 Bio-Rad Laboratories, Inc. Digitale analyse von analyten
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
EP3090063B1 (de) 2013-12-31 2019-11-06 Bio-Rad Laboratories, Inc. Verfahren zur detektion von latentem retrovirus
US9810610B2 (en) 2014-09-17 2017-11-07 Hologic, Inc. Method of partial lysis and assay
WO2016048138A1 (en) 2014-09-22 2016-03-31 Rijksuniversiteit Groningen Biomarkers for cervical cancer.
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
US10998178B2 (en) 2017-08-28 2021-05-04 Purdue Research Foundation Systems and methods for sample analysis using swabs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6342491B1 (en) * 1991-05-21 2002-01-29 American Home Products Corporation Method of treating estrogen receptor positive carcinoma with 17 α-dihydroequilin
US6331393B1 (en) * 1999-05-14 2001-12-18 University Of Southern California Process for high-throughput DNA methylation analysis
WO2001075172A1 (en) * 2000-03-31 2001-10-11 University Of Southern California Epigenetic sequences for esophageal adenocarcinoma
AUPQ901700A0 (en) * 2000-07-26 2000-08-17 National Cancer Centre Of Singapore Pte Ltd Molecular markers
ATE519862T1 (de) * 2002-08-20 2011-08-15 Millennium Pharm Inc Zusammensetzungen, kits und verfahren zur identifizierung, beurteilung, vorbeugung und therapie von gebärmutterhalskrebs
WO2004087957A2 (en) * 2003-04-03 2004-10-14 Oncomethylome Sciences S.A. Hypermethylated genes and cervical cancer
JP2007531512A (ja) * 2003-11-10 2007-11-08 エピゲノミクス アーゲー 婦人科細胞増殖障害の分析方法

Also Published As

Publication number Publication date
WO2006007980A2 (en) 2006-01-26
WO2006007980A3 (en) 2006-04-06
EP1769087B1 (de) 2008-09-10
EP1769087A2 (de) 2007-04-04
CA2574165A1 (en) 2006-01-26
DE602005009702D1 (de) 2008-10-23
EP1985715A3 (de) 2008-12-31
US20090023137A1 (en) 2009-01-22
EP1985715A2 (de) 2008-10-29

Similar Documents

Publication Publication Date Title
ATE408032T1 (de) Esr1 und gebärmutterhalskrebs
EA200702203A1 (ru) Способы и нуклеиновые кислоты для анализов клеточных пролиферативных нарушений
WO2004066941A3 (en) Expression profiles for colon cancer and methods of use
WO2008039769A3 (en) Methods and devices for analyzing small rna molecules
PL1712639T3 (pl) Sposób diagnozowania nowotworu przez wykrywanie krążącego DNA i RNA
ATE450547T1 (de) Eml4-alk-fusionsgen
WO2006071466A8 (en) Methods and nucleic acids for the analysis of gene expression associated with the prognosis of prostate cell proliferative disorders
PT1687609E (pt) Sondas fluorescentes para a detecção de adn por hibridação com uma maior sensibilidade e menor ruído de fundo
ATE546550T1 (de) Verfahren zum nachweis von hpv sowie sonden, primer und kits
WO2007058968A3 (en) Gene expression profiles and methods of use
DK2019872T3 (da) Fremgangsmåde til forudsigelse af modtageligheden over for TNF-blokkere
DK2114990T3 (da) Fremgangsmåde til forudsigelse af NSCLC-patienters respons på behandling med en EGFR-TK-inhibitor
WO2005059108A3 (en) Gene expression profiles and methods of use
PL1895015T3 (pl) Sposób i zestaw do wykrywania gatunków bakteryjnych za pomocą analizy DNA
EP2254897A4 (de) Verfahren, reagentien und kits zum nachweis von nukleinsäuremolekülen
DE602005020592D1 (de) Cpg-amplicon und array-protokoll
WO2006116016A3 (en) Molecular determinants of egfr kinase inhibitor response in glioblastoma
WO2005032495A8 (en) Gene expression profiles and methods of use
PT1907588E (pt) Ensaios para determinação da resistência aos medicamentos da classe das equinocandinas
WO2011133949A3 (en) Genetic risk analysis in reward deficiency syndrome
WO2008063655A3 (en) Dna methylation markers and methods of use
WO2004087957A3 (en) Hypermethylated genes and cervical cancer
WO2006022619A3 (en) Methods for identifying risk of type ii diabetes and treatments thereof
WO2007041238A3 (en) Methods of identification and use of gene signatures
WO2007003397A3 (en) Method and nucleic acids for the improved treatment of cancers

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties